Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|May 1, 1996
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolismK E Thummel, D O'Shea, M F Paine, et al.
Clinical Pharmacology and Therapeutics|January 1, 1995
The erythromycin breath test predicts the clearance of midazolamK S Lown, K E Thummel, P E Benedict, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 17, 1999
A comparison of 1H8- and 2H8-toluene toxicokinetics in menC H Pierce, T A Lewandowski, R L Dills, et al.
American Journal of Hypertension|July 1, 1992
Insulin resistance and abnormal electrocardiograms in patients with high blood pressureW H Sheu, C Y Jeng, S M Shieh, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1993
Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemiaW H Sheu, S M Shieh, M M Fuh, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolismM F Paine, M Khalighi, J M Fisher, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 1998
Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbitsJ L Scism, K M Powers, A A Artru, et al.
Clinical Pharmacology and Therapeutics|December 30, 2011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypeK R Crews, A Gaedigk, H M Dunnenberger, et al.
Pageof 15